Development
Nutrien Ltd.
NTR
$55.69
-$0.02-0.04%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -24.13% | -18.55% | -5.86% | 18.74% | 37.79% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -24.13% | -18.55% | -5.86% | 18.74% | 37.79% |
| Cost of Revenue | -9.17% | -3.38% | 6.76% | 16.49% | 23.70% |
| Gross Profit | -45.06% | -38.87% | -23.11% | 22.33% | 63.93% |
| SG&A Expenses | -0.89% | -5.53% | -3.46% | -0.57% | 5.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -40.87% | -37.72% | -1.36% | 41.82% | 108.14% |
| Total Operating Expenses | -9.73% | -5.58% | 4.72% | 14.59% | 23.42% |
| Operating Income | -63.89% | -52.84% | -34.47% | 33.54% | 103.05% |
| Income Before Tax | -80.95% | -67.72% | -43.24% | 54.66% | 145.83% |
| Income Tax Expenses | -73.82% | -56.63% | -34.45% | 52.96% | 158.75% |
| Earnings from Continuing Operations | -83.32% | -71.40% | -46.16% | 55.22% | 141.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 11.11% | 3.70% | 16.67% | 7.41% | -3.85% |
| Net Income | -83.58% | -71.64% | -46.29% | 55.61% | 142.94% |
| EBIT | -63.89% | -52.84% | -34.47% | 33.54% | 103.05% |
| EBITDA | -53.67% | -44.42% | -28.28% | 27.88% | 77.40% |
| EPS Basic | -82.11% | -69.26% | -42.50% | 63.59% | 155.15% |
| Normalized Basic EPS | -68.42% | -54.62% | -32.08% | 44.28% | 126.27% |
| EPS Diluted | -82.07% | -69.26% | -42.49% | 63.37% | 154.96% |
| Normalized Diluted EPS | -68.37% | -54.56% | -32.00% | 44.34% | 126.26% |
| Average Basic Shares Outstanding | -7.83% | -8.96% | -8.62% | -7.02% | -5.46% |
| Average Diluted Shares Outstanding | -7.98% | -9.08% | -8.71% | -7.07% | -5.44% |
| Dividend Per Share | 10.42% | 8.95% | 7.45% | 5.91% | 4.35% |
| Payout Ratio | 5.10% | 2.44% | 0.81% | -0.37% | -0.59% |